down arrow

Alpa Laboratorie

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE385I01010
  • NSEID: ALPA
  • BSEID: 532878
INR
105.60
4.05 (3.99%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 14.89 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

102.05105.60

52 Week

71.00144.60
Valuation
Technical
Day's Volume

CASH

14.89 k (-73.87%) Volume

Shareholding (Dec 2024)

FII

0.35%

Held by 1 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

57.29%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor Management Efficiency with a low ROE of 9.38%

  • The company has been able to generate a Return on Equity (avg) of 9.38% signifying low profitability per unit of shareholders funds
2

Stock is technically in a Bearish range

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 222 Cr (Micro Cap)

stock-summary
P/E

8.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.65

stock-summary
Return on Equity

12.65%

stock-summary
Price to Book

1.30

Revenue and Profits (1 Year):
Net Sales:
26 Cr
(Quarterly Results - Dec 2024)
Net Profit:
9 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-13.12%
0%
-13.12%
1 Year
13.61%
0%
13.61%
2 Years
83.88%
0%
83.88%
3 Years
28.94%
0%
28.94%
4 Years
95.92%
0%
95.92%
5 Years
378.91%
0%
378.91%

Alpa Laboratorie for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
2.04%
EBIT Growth (5y)
43.59%
EBIT to Interest (avg)
5.78
Debt to EBITDA (avg)
1.64
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.78
Tax Ratio
16.75%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.35%
ROCE (avg)
10.74%
ROE (avg)
9.38%
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
33
Price to Book Value
1.30
EV to EBIT
17.94
EV to EBITDA
13.20
EV to Capital Employed
1.85
EV to Sales
1.11
PEG Ratio
0.21
Dividend Yield
NA
ROCE (Latest)
13.05%
ROE (Latest)
12.65%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.35%)

Promoter with highest holding

Paresh Chawla (17.52%)

Highest Public shareholder

None

Individual Investors Holdings

36.8%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 4.85% vs 16.32% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 15.73% vs 50.78% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "26.15",
          "val2": "24.94",
          "chgp": "4.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.74",
          "val2": "3.32",
          "chgp": "-77.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.09",
          "val2": "0.05",
          "chgp": "80.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8.90",
          "val2": "7.69",
          "chgp": "15.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.83%",
          "val2": "13.31%",
          "chgp": "-10.48%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -19.79% vs 60.79% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 46.06% vs 205.94% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "46.38",
          "val2": "57.82",
          "chgp": "-19.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.80",
          "val2": "2.16",
          "chgp": "75.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.04",
          "chgp": "150.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.04",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "12.78",
          "val2": "8.75",
          "chgp": "46.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.19%",
          "val2": "3.74%",
          "chgp": "4.45%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -14.80% vs 34.55% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 63.50% vs 66.17% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "72.53",
          "val2": "85.13",
          "chgp": "-14.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.54",
          "val2": "4.59",
          "chgp": "-1.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.19",
          "val2": "0.06",
          "chgp": "216.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.04",
          "val2": "0.02",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "21.68",
          "val2": "13.26",
          "chgp": "63.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.26%",
          "val2": "5.39%",
          "chgp": "0.87%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 17.63% vs -17.66% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 32.86% vs -10.36% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "108.74",
          "val2": "92.44",
          "chgp": "17.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.10",
          "val2": "7.56",
          "chgp": "7.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.36",
          "val2": "0.22",
          "chgp": "63.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "16.78",
          "val2": "12.63",
          "chgp": "32.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.45%",
          "val2": "8.18%",
          "chgp": "-0.73%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
26.15
24.94
4.85%
Operating Profit (PBDIT) excl Other Income
0.74
3.32
-77.71%
Interest
0.09
0.05
80.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
8.90
7.69
15.73%
Operating Profit Margin (Excl OI)
2.83%
13.31%
-10.48%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 4.85% vs 16.32% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 15.73% vs 50.78% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
46.38
57.82
-19.79%
Operating Profit (PBDIT) excl Other Income
3.80
2.16
75.93%
Interest
0.10
0.04
150.00%
Exceptional Items
0.04
0.00
Consolidate Net Profit
12.78
8.75
46.06%
Operating Profit Margin (Excl OI)
8.19%
3.74%
4.45%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -19.79% vs 60.79% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 46.06% vs 205.94% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
72.53
85.13
-14.80%
Operating Profit (PBDIT) excl Other Income
4.54
4.59
-1.09%
Interest
0.19
0.06
216.67%
Exceptional Items
0.04
0.02
100.00%
Consolidate Net Profit
21.68
13.26
63.50%
Operating Profit Margin (Excl OI)
6.26%
5.39%
0.87%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -14.80% vs 34.55% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 63.50% vs 66.17% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
108.74
92.44
17.63%
Operating Profit (PBDIT) excl Other Income
8.10
7.56
7.14%
Interest
0.36
0.22
63.64%
Exceptional Items
0.00
0.00
Consolidate Net Profit
16.78
12.63
32.86%
Operating Profit Margin (Excl OI)
7.45%
8.18%
-0.73%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 17.63% vs -17.66% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 32.86% vs -10.36% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Alpa Laboratories Ltd stock-summary
stock-summary
Alpa Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
M/s Alpa Laboratories, formed in 1967, was incorporated as Private Limited Company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations. In 1998, the Company was converted into a Public Limited Company with effect from September 3, 1998 with the name of "Alpa Laboratories Limited".
Company Coordinates stock-summary
Company Details
33/2 Pigdamber, A B Road Rau Indore Madhya Pradesh : 453446
stock-summary
Tel: 91-731-4294567
stock-summary
http://www.alpalabs.in
stock-summary
is@alpalabs.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."